Safety and Effectiveness of Nabiximols Oromucosal Spray as Add-on Therapy in Participants With Spasticity Due to Multiple Sclerosis

NCT04203498 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

139

Enrollment

INDUSTRY

Sponsor class

Stopped This study was terminated based on a business decision by the Sponsor.

Conditions

Multiple Sclerosis (MS)

Interventions

DRUG: Nabiximols
DRUG: Placebo

Sponsor

Jazz Pharmaceuticals